China targets Germany's Bayer in drug price probe

Sep 13, 2013

Chinese authorities have visited an office of German pharmaceutical giant Bayer, the company said Friday, making it the latest target in a probe of foreign drug firms over high prices.

One of its offices was visited at the end of last month to investigate a potential case of "", Bayer HealthCare said in a statement to AFP.

China is mounting a sweeping probe into foreign pharmaceutical firms, accusing some of abusing their monopoly positions to boost prices unfairly.

Police are also investigating Britain's GlaxoSmithKline (GSK) over allegations employees gave bribes to sell its products.

Authorities have detained at least four GSK executives in the case, while state media has alleged the firm was responsible and not just individual employees.

Bayer said it was visited by officials of a local branch of the State Administration for Industry & Commerce, which handles market supervision and regulation.

It did not identify the location.

The company said it had strict compliance rules in place and would investigate of violations of its policy by employees.

US drugmaker Eli Lilly and France's Sanofi have both come under scrutiny after anonymous whistleblowers cited by Chinese state media claimed that employees paid .

Eli Lilly said it was investigating, while Sanofi said it was taking the claims "seriously".

Chinese authorities are investigating other industries over pricing, state media has reported, with the moves sending a chill through the foreign business community in the country.

Explore further: Sony forecasts $2B loss as smartphones lag (Update)

add to favorites email to friend print save as pdf

Related Stories

China state media raises pressure on Britain's GSK

Sep 03, 2013

Chinese state media increased the pressure on British pharmaceutical giant GlaxoSmithKline (GSK) over a bribery investigation Tuesday, accusing the firm of being responsible rather than individual employees.

China shuts travel agency in GSK bribery case

Jul 19, 2013

China has shut down a travel agency which served as a conduit for bribes allegedly given by staff of British drug firm GlaxoSmithKline (GSK), the government and state media said.

China launches crackdown on drug industry

Jul 17, 2013

(AP)—China announced a crackdown Wednesday on misconduct in its drug market, stepping up pressure on the problem-prone industry while it pursues a bribery investigation of GlaxoSmithKline.

Chinese police say Glaxo employees bribed doctors

Jul 11, 2013

China's police ministry accused executives of pharmaceutical supplier GlaxoSmithKline on Thursday of conducting a large and long-running bribery campaign to persuade doctors to prescribe drugs.

Chinese police probe kickbacks by Foxconn managers

Jan 10, 2013

(AP)—Hon Hai Precision, a leading maker of iPhones and other high-tech gadgets, has said it is working with Chinese police probing allegations that its employees solicited kickbacks from suppliers.

Recommended for you

Apple iPhone lacks 'key' licence in China

1 hour ago

Apple's iPhone 6 still lacks a key network access licence in China, state media confirmed Thursday on the eve of its global launch, breaking official silence on why sales of the smartphone will be delayed.

Ericsson to stop making modems, shed hundreds of jobs

1 hour ago

Swedish telecom equipment company Ericsson said on Thursday that it would stop developing modems, a decision affecting almost 1,600 employees worldwide which is expected to lead to hundreds of job cuts.

Germany's Bayer says will float chemicals division

4 hours ago

German chemicals and pharmaceuticals giant Bayer, maker of Aspirin painkiller, said on Thursday it intends to float its chemicals Material Science division to focus on its life sciences activities in human and animal health.

Sony forecasts $2B loss as smartphones lag (Update)

Sep 17, 2014

Sony expects its annual loss to swell to $2 billion and has canceled dividends for the first time in more than half a century after writing down the value of its troubled smartphone business.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

tarheelchief
not rated yet Sep 13, 2013
Since chemists from India and China went to US,Russian,EU universities,it's very hard to maintain a patent on any drug.
In the now famous HIV case the Indians produced drugs which cost less than twelve dollars a month.Similar drugs from the US cost well over ten thousand dollars a year.
If the Chinese label a German firm predatory,they can simply take their drugs and perform titrations to discover the ingredients and produce their own domestic drug industry.
The EU socialist nations can and will send out bids for the most common medications used by their citizens.I am not sure why Americans feel they cannot do the same thing.